Honda Masaki, Takeichi Takayuki, Hashimoto Shintaro, Yoshii Daiki, Isono Kaori, Hayashida Shintaro, Ohya Yuki, Yamamoto Hidekazu, Sugawara Yasuhiko, Inomata Yukihiro
Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan
J Immunol. 2017 Feb 15;198(4):1718-1728. doi: 10.4049/jimmunol.1601773. Epub 2017 Jan 6.
Neutrophils are considered responsible for the pathophysiological changes resulting from hepatic ischemia-reperfusion (I/R) injury, which is a complication of trauma, shock, liver resection, and transplantation. Recently, evidence is accumulating that formyl-peptide receptor (FPR) signaling constitutes an important danger signal that guides neutrophils to sites of inflammation. This study aimed to investigate dynamic neutrophil recruitment using two-photon laser-scanning microscopy (TPLSM) in response to FPR1 blockade during hepatic I/R. LysM-eGFP mice were subjected to partial warm hepatic I/R. They were pretreated with an FPR1 antagonist, cyclosporine H (CsH), or formyl peptide, fMLF. Liver was imaged after hepatic laser irradiation or I/R using the TPLSM technique. CsH treatment alleviated hepatic I/R injury, as evidenced by decreased serum transaminase levels, reduced hepatocyte necrosis/apoptosis, and diminished inflammatory cytokine, chemokine, and oxidative stress. In contrast, systemic administration of fMLF showed few effects. Time-lapse TPLSM showed that FPR1 blockade inhibited the accumulation of neutrophils in the necrotic area induced by laser irradiation in vivo. In the CsH-treated I/R group, the number and crawling velocity of neutrophils in the nonperfused area were lower than those in the control group. Meanwhile, FPR1 blockade did not affect monocyte/macrophage recruitment. Hepatic I/R promoted the retention of neutrophils and their active behavior in the spleen, whereas CsH treatment prevented their changes. Intravital TPLSM revealed that formyl-peptide-FPR1 signaling is responsible for regulating neutrophil chemotaxis to allow migration into the necrotic area in hepatic I/R. Our findings suggest effective approaches for elucidating the mechanisms of immune cell responses in hepatic I/R.
中性粒细胞被认为是肝缺血再灌注(I/R)损伤所致病理生理变化的原因,肝缺血再灌注损伤是创伤、休克、肝切除和移植的一种并发症。最近,越来越多的证据表明,甲酰肽受体(FPR)信号构成一种重要的危险信号,可引导中性粒细胞到达炎症部位。本研究旨在使用双光子激光扫描显微镜(TPLSM)研究肝I/R期间FPR1阻断后中性粒细胞的动态募集情况。对LysM-eGFP小鼠进行部分肝脏热缺血再灌注。它们分别用FPR1拮抗剂环孢素H(CsH)或甲酰肽fMLF进行预处理。在肝脏激光照射或I/R后,使用TPLSM技术对肝脏进行成像。CsH治疗减轻了肝I/R损伤,血清转氨酶水平降低、肝细胞坏死/凋亡减少以及炎性细胞因子、趋化因子和氧化应激减轻均证明了这一点。相比之下,全身给予fMLF几乎没有效果。延时TPLSM显示,FPR1阻断可抑制体内激光照射诱导的坏死区域中性粒细胞的聚集。在CsH治疗的I/R组中,非灌注区域中性粒细胞的数量和爬行速度低于对照组。同时,FPR1阻断不影响单核细胞/巨噬细胞的募集。肝I/R促进中性粒细胞在脾脏中的滞留及其活跃行为,而CsH治疗可防止这些变化。活体TPLSM显示,甲酰肽-FPR1信号负责调节中性粒细胞趋化作用,使其能够迁移到肝I/R的坏死区域。我们的研究结果为阐明肝I/R中免疫细胞反应机制提供了有效的方法。